Associate
Hyman Phelps
Washington, District of Columbia, United States
Kalie focuses her practice on regulatory strategy and compliance, primarily for pharmaceutical manufacturers, distributors, and pharmacies. Recently, she has assisted manufacturers with FDA Form 483 responses, ongoing inspection remediation, and internal investigations. She also advises clients on state licensing, board actions, controlled substance issues, DSCSA compliance, and regulatory due diligence.
Let's Get Into the Weed(s): A Detailed Review of DEA's Proposed Rescheduling of Marijuana.
Saturday, November 9, 2024
10:10 AM – 11:10 AM MT
